View in EDS HTML Full Text PDF Full Text

Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin among Patients with Obesity and Type 2 Diabetes.

Saved in:
Bibliographic Details
Title: Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin among Patients with Obesity and Type 2 Diabetes.
Authors: Szekeres, Zsolt1 (AUTHOR), Sandor, Barbara1 (AUTHOR), Bognar, Zita2 (AUTHOR), Ramadan, Fadi H. J.2 (AUTHOR), Palfi, Anita1 (AUTHOR), Bodis, Beata3 (AUTHOR), Toth, Kalman4 (AUTHOR), Szabados, Eszter1 (AUTHOR) szabados.eszter@pte.hu
Source: International Journal of Molecular Sciences. Mar2023, Vol. 24 Issue 5, p4405. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16616596
DOI:10.3390/ijms24054405